Skip to main content
Premium Trial:

Request an Annual Quote

Caprotec Signs Distribution Pact with Funakoshi

NEW YORK (GenomeWeb News) —Caprotec Bioanalytics has tapped Funakoshi to market and sell its research products in Japan, the Berlin-based company said today.

Under an exclusive agreement, Funakoshi will distribute Caprotec products based on its Capture Compound Mass Spectrometry technology. The CCMS technology consists of small, tri-functional molecules that are used to isolate proteins from biological samples, which are then identified and characterized by mass spectrometry.

"To establish a distribution channel for our products into the Japanese market is of strategic importance to us," Caprotec Bioanalytics CEO Hubert Köster said in a statement.

The Scan

Driving Malaria-Carrying Mosquitoes Down

Researchers from the UK and Italy have tested a gene drive for mosquitoes to limit the spread of malaria, NPR reports.

Office Space to Lab Space

The New York Times writes that some empty office spaces are transforming into lab spaces.

Prion Pause to Investigate

Science reports that a moratorium on prion research has been imposed at French public research institutions.

Genome Research Papers on Gut Microbe Antibiotic Response, Single-Cell RNA-Seq Clues to Metabolism, More

In Genome Research this week: gut microbial response to antibiotic treatment, approach to gauge metabolic features from single-cell RNA sequencing, and more.